Impact of End-to-End Lead Time on Service Level and Working Capital in a Pharmaceutical Company
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Tez |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | http://hdl.handle.net/1721.1/102016 |
| _version_ | 1826192721880023040 |
|---|---|
| author | Girsch, Thilo Bautista, Kristin |
| author_facet | Girsch, Thilo Bautista, Kristin |
| author_sort | Girsch, Thilo |
| collection | MIT |
| first_indexed | 2024-09-23T09:27:55Z |
| format | Thesis |
| id | mit-1721.1/102016 |
| institution | Massachusetts Institute of Technology |
| language | English |
| last_indexed | 2024-09-23T09:27:55Z |
| publishDate | 2016 |
| record_format | dspace |
| spelling | mit-1721.1/1020162019-04-11T06:29:48Z Impact of End-to-End Lead Time on Service Level and Working Capital in a Pharmaceutical Company Girsch, Thilo Bautista, Kristin end-to-end lead time working capital optimization 2016-03-31T18:15:54Z 2016-03-31T18:15:54Z 2016-03-31 Thesis http://hdl.handle.net/1721.1/102016 en SCALE Research Reports;ZLC-2012-1 Attribution 4.0 International (CC BY 4.0) http://creativecommons.org/licenses/by/4.0/ application/pdf |
| spellingShingle | end-to-end lead time working capital optimization Girsch, Thilo Bautista, Kristin Impact of End-to-End Lead Time on Service Level and Working Capital in a Pharmaceutical Company |
| title | Impact of End-to-End Lead Time on Service Level and Working Capital in a Pharmaceutical Company |
| title_full | Impact of End-to-End Lead Time on Service Level and Working Capital in a Pharmaceutical Company |
| title_fullStr | Impact of End-to-End Lead Time on Service Level and Working Capital in a Pharmaceutical Company |
| title_full_unstemmed | Impact of End-to-End Lead Time on Service Level and Working Capital in a Pharmaceutical Company |
| title_short | Impact of End-to-End Lead Time on Service Level and Working Capital in a Pharmaceutical Company |
| title_sort | impact of end to end lead time on service level and working capital in a pharmaceutical company |
| topic | end-to-end lead time working capital optimization |
| url | http://hdl.handle.net/1721.1/102016 |
| work_keys_str_mv | AT girschthilo impactofendtoendleadtimeonservicelevelandworkingcapitalinapharmaceuticalcompany AT bautistakristin impactofendtoendleadtimeonservicelevelandworkingcapitalinapharmaceuticalcompany |